SCHEMBL7690278

SCHEMBL7690278

Cc1cccc(Oc2cc(CC(c3cnc(C)[nH]3)N3CCN(C(=O)c4ccccc4O)CC3)ccc2C#N)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 1/20 0.36
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 2/20 0.33
HTT P42858 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MAPT P10636 2/20 0.33
USP2 O75604 1/20 0.33
LMNA P02545 1/20 0.33
HPGD P15428 1/20 0.33
ALOX15 P16050 1/20 0.33
TSHR P16473 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
HSD17B10 Q99714 1/20 0.33
CFTR P13569 1/20 0.32
HRH3 Q9Y5N1 1/20 0.32
GAA P10253 1/20 0.31
CLK1 P49759 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
SCN5A Q14524 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7685752 0.93 HTT (0.42) FFAR4KDM4EALDH1A1HTTSMN1; SMN2
SCHEMBL7683709 0.91 ALDH1A1 (0.35) FFAR4KDM4EALDH1A1HTTSMN1; SMN2
SCHEMBL7689761 0.90 FFAR4 (0.35) FFAR4KDM4EALDH1A1HTTSMN1; SMN2
SCHEMBL7683737 0.89 KDM4E (0.39) FFAR4KDM4EALDH1A1HTTSMN1; SMN2
SCHEMBL7690630 0.88 FFAR4 (0.35) FFAR4KDM4EALDH1A1HTTSMN1; SMN2
SCHEMBL7690259 0.87 FFAR4 (0.35) FFAR4KDM4EALDH1A1HTTSMN1; SMN2
SCHEMBL7690192 0.87 MAPT (0.33) KDM4EALDH1A1HTTSMN1; SMN2MAPT
SCHEMBL7688314 0.86 FFAR4 (0.35) FFAR4KDM4EALDH1A1HTTSMN1; SMN2
SCHEMBL7683560 0.86 FFAR4 (0.38) FFAR4GRM5
SCHEMBL7683768 0.81 FNTA (0.37) KDM4EALDH1A1HTTSMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020052363-A1 Inhibitors of prenyl-protein transferase DINSMORE CHRISTOPHER J (US) 2002-05-02 US claimed
WO-2001060369-A1 INHIBITORS OF PRENYL-PROTEIN TRANSFERASE MERCK & CO., INC. (US) 2001-08-23 WO claimed
US-20020052363-A1 Inhibitors of prenyl-protein transferase DINSMORE CHRISTOPHER J (US) 2002-05-02 US disclosed
WO-2001060369-A1 INHIBITORS OF PRENYL-PROTEIN TRANSFERASE MERCK & CO., INC. (US) 2001-08-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020052363-A1 Inhibitors of prenyl-protein transferase FNTA, FNTB, PTAR1 FFAR4 4314/4885KDM4E 2677/4885ALDH1A1 1461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.